Poly-paclitaxel/cyclodextrin-SPION nano-assembly for magnetically guided drug delivery system
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Jeon, H | - |
dc.contributor.author | Jihoon Kim | - |
dc.contributor.author | Yeong Mi Lee | - |
dc.contributor.author | Jinhwan Kim | - |
dc.contributor.author | Hyung Woo Choi | - |
dc.contributor.author | Junseok Lee | - |
dc.contributor.author | Park, H | - |
dc.contributor.author | Kang, Y | - |
dc.contributor.author | Kim, IS | - |
dc.contributor.author | Lee, BH | - |
dc.contributor.author | Hoffman, AS | - |
dc.contributor.author | Won Jong Kim | - |
dc.date.available | 2018-12-13T12:23:04Z | - |
dc.date.created | 2018-03-15 | - |
dc.date.issued | 2016-06 | - |
dc.identifier.issn | 0168-3659 | - |
dc.identifier.uri | https://pr.ibs.re.kr/handle/8788114/5021 | - |
dc.description.abstract | This work demonstrates the development of magnetically guided drug delivery systems and its potential on efficient anticancer therapy. The magnetically guided drug delivery system was successfully developed by utilizing superparamagnetic iron oxide nanoparticle, beta-cyclodextrin, and polymerized paclitaxel. Multivalent host-guest interactions between beta-cyclodextrin-conjugated superparamagnetic iron oxide nanoparticle and polymerized paclitaxel allowed to load the paclitaxel and the nanoparticle into the nano-assembly. Clusterized superparamagnetic iron oxide nanoparticles in the nano-assembly permitted the rapid and efficient targeted drug delivery. Compared to the control groups, the developed nano-assembly showed the enhanced anticancer effects in vivo as well as in vitro. Consequently, the strategy of the use of superparamagnetic nanoparticles and multivalent host-guest interactions has a promising potential for developing the efficient drug delivery systems. (C) 2016 Elsevier B.V. All rights reserved | - |
dc.description.uri | 1 | - |
dc.language | 영어 | - |
dc.publisher | ELSEVIER SCIENCE BV | - |
dc.subject | Multivalent host-guest chemistry | - |
dc.subject | Paclitaxel | - |
dc.subject | Cyclodextrin | - |
dc.subject | SPION | - |
dc.subject | Magnetic-guided drug delivery | - |
dc.title | Poly-paclitaxel/cyclodextrin-SPION nano-assembly for magnetically guided drug delivery system | - |
dc.type | Article | - |
dc.type.rims | ART | - |
dc.identifier.wosid | 000376444600008 | - |
dc.identifier.scopusid | 2-s2.0-84954306031 | - |
dc.identifier.rimsid | 62515 | - |
dc.contributor.affiliatedAuthor | Jihoon Kim | - |
dc.contributor.affiliatedAuthor | Yeong Mi Lee | - |
dc.contributor.affiliatedAuthor | Hyung Woo Choi | - |
dc.contributor.affiliatedAuthor | Junseok Lee | - |
dc.contributor.affiliatedAuthor | Won Jong Kim | - |
dc.identifier.doi | 10.1016/j.jconrel.2016.01.006 | - |
dc.identifier.bibliographicCitation | JOURNAL OF CONTROLLED RELEASE, v.231, pp.68 - 76 | - |
dc.citation.title | JOURNAL OF CONTROLLED RELEASE | - |
dc.citation.volume | 231 | - |
dc.citation.startPage | 68 | - |
dc.citation.endPage | 76 | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.subject.keywordPlus | IRON-OXIDE NANOPARTICLES | - |
dc.subject.keywordPlus | BETA-CYCLODEXTRIN | - |
dc.subject.keywordPlus | IN-VIVO | - |
dc.subject.keywordPlus | CANCER THERAPEUTICS | - |
dc.subject.keywordPlus | ANTICANCER DRUG | - |
dc.subject.keywordPlus | THERAPY | - |
dc.subject.keywordPlus | PACLITAXEL | - |
dc.subject.keywordPlus | RELEASE | - |
dc.subject.keywordPlus | CARRIER | - |
dc.subject.keywordPlus | TUMORS | - |
dc.subject.keywordAuthor | Multivalent host-guest chemistry | - |
dc.subject.keywordAuthor | Paclitaxel | - |
dc.subject.keywordAuthor | Cyclodextrin | - |
dc.subject.keywordAuthor | SPION | - |
dc.subject.keywordAuthor | Magnetic-guided drug delivery | - |